Assessment of Commercial Fungicides against Onion (Allium cepa) Basal Rot Disease Caused by Fusarium oxysporum f. sp. cepae and Fusarium acutatum

评估商业杀菌剂对由尖孢镰刀菌洋葱专化型和尖孢镰刀菌引起的洋葱(Allium cepa)基腐病的防治效果

阅读:1

Abstract

The onion basal rot disease is a worldwide threat caused by species of the genus Fusarium. Today, Israel's control of this disease is limited to a four-year growth cycle and Metam sodium soil disinfection. Here, commercial chemical fungicides were evaluated as control treatments against two of the primary pathogens involved, F. oxysporum f. sp. cepae and F. Acutatum. Out of 10 fungicides tested on culture plates, 3, Prochloraz, Azoxystrobin + Tebuconazole, and Fludioxonil + Sedaxen, had strong inhibitory effects on mycelial growth and were selected and tested in seeds in vitro. The preparations were applied as a seed coating and tested in two commercial cultivars, Riverside (Orlando, white cv.) and Noam (red cv.). Prochloraz (0.3% w/w concentration), the most promising compound, was efficient in reducing the Noam cv. sprouts' disease symptoms. This preparation had no harmful in situ-toxicity effect and did not influence the plants' seed germination and early development. In Noam cv. potted 30-day-old sprouts, the Prochloraz treatment was able to reduce the harmful impact of F. oxysporum f. sp. cepae. on the seedlings' wet biomass, but was not effective in the Riverside cv. or against the F. acutatum pathogen. This suggests that future protective strategies must include an effective protective suit tailored to each of the pathogen species involved and the onion cultivar. The methods presented in this work can be applied for rapidly scanning multiple compounds while gradually ruling out ineffective ones. Eventually, this screening will enable field testing of the highest potential fungicides that successfully pass the pot experiments.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。